Detalhe da pesquisa
1.
Factors associated with uptake of contraceptives among HIV positive women on dolutegravir based anti-retroviral treatment-a cross sectional survey in urban Uganda.
BMC Womens Health
; 22(1): 262, 2022 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35761248
2.
The burden of drug resistant tuberculosis in a predominantly nomadic population in Uganda: a mixed methods study.
BMC Infect Dis
; 21(1): 950, 2021 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34521382
3.
Phase I EnACT Trial of the Safety and Tolerability of a Novel Oral Formulation of Amphotericin B.
Antimicrob Agents Chemother
; 64(10)2020 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32747357
4.
An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir.
BMC Infect Dis
; 19(1): 280, 2019 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30909871
5.
High prevalence and long duration of nervous system and psychiatric adverse drug reactions in Ugandan patients taking efavirenz 600 mg daily.
J Antimicrob Chemother
; 73(11): 3158-3161, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30085168
6.
Dolutegravir use over 48 weeks is not associated with worsening insulin resistance and pancreatic beta cell function in a cohort of HIV-infected Ugandan adults.
Res Sq
; 2023 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37502917
7.
Blood glucose outcomes of anti-retroviral therapy naïve Ugandan people with HIV with pre-diabetes mellitus initiated on dolutegravir for 48 weeks.
Res Sq
; 2023 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37577475
8.
Prevalence of overweight and obesity and associated factors among people living with HIV attending a tertiary care clinic in Uganda.
BMC Nutr
; 8(1): 107, 2022 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36167612
9.
An Interactive Voice Response Software to Improve the Quality of Life of People Living With HIV in Uganda: Randomized Controlled Trial.
JMIR Mhealth Uhealth
; 9(2): e22229, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33570497
10.
Erratum: Symptomatic cerebrospinal fluid HIV-1 escape in two patients on second-line antiretroviral therapy in Uganda.
Oxf Med Case Reports
; 2020(6): omz121, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32617171
11.
The Potential Teratogenicity Alert for Women Conceiving on Dolutegravir-Based Regimens: An Assessment of Risk Communication by an Urban HIV Clinic in Uganda and Choices made by Women.
Drug Saf
; 43(11): 1133-1140, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32926356
12.
Symptomatic cerebrospinal fluid HIV-1 escape in two patients on second-line antiretroviral therapy in Uganda.
Oxf Med Case Reports
; 2019(2): omy132, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30800328
13.
Dolutegravir-associated hyperglycaemia in patients with HIV.
Lancet HIV
; 7(7): e461-e462, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32105626
14.
Boosted lopinavir vs boosted atazanavir in patients failing a NNRTI first line regimen in an urban clinic in Kampala.
J Int AIDS Soc
; 17(4 Suppl 3): 19792, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25397536